Catalog No.: 101241
Net Contents: 100mg AggRecetin (Ristocetin)
AGGRECETIN® 100mg Ristocetin
AggRecetin®: A Pinnacle of Platelet Precision with Over 90% Ristocetin A
AggRecetin® (Ristocetin) is the required reagent, used in combination with other IVD components, to perform a Ristocetin Cofactor Activity test on Platelet Rich Plasma.
-
Mediates Platelet Adhesion (Agglutination) by Binding to Collagen and Platelets
-
Causes vWF to Bind to the Gp1B Platelet Receptor
-
Used with Patient Platelet Poor Plasma and Fixed Platelets to Perform the Ristocetin Cofactor Activity Assay
-
Determines the Presence and Integrity of the Platelet Glycoprotein (GP) Ibα-V-IX Complex and von Willebrand Factor (VWF) Interaction when Performed Using Platelet Rich Plasma
-
Causes Ristocetin Induced Platelet Aggregation (RIPA) in Platelet Rich Plasma Samples when AggRecetin is Added in Two Concentrations
PRODUCT DETAILS
Discover the extraordinary capabilities of AggRecetin®, a lyophilized derivative of Ristocetin A Sulfate sourced from the mysterious chemical structures of Nocardia lurida. Boasting an impressive concentration of over 90% Ristocetin A, AggRecetin stands as a beacon of purity and potency.
Within the realm of platelet dynamics, AggRecetin showcases remarkable functionality. In the intricate dance between AggRecetin and the von Willebrand factor, a mesmerizing phenomenon takes center stage. This substance uniquely induces the agglutination of platelets, an observable process in both platelet-rich plasma and standardized fixed platelet suspensions.
Delving into the molecular intricacies orchestrated by Ristocetin, it becomes apparent that this substance acts as a catalyst, igniting a fascinating interplay between platelets and von Willebrand factor. The witnessed agglutination in platelet-rich plasma or standardized fixed platelet suspensions not only underscores AggRecetin's potency but also provides a nuanced insight into the intricate mechanisms governing platelet behavior. This revelation carries significant implications in the broader context of hemostasis and coagulation, enriching our understanding of the intricate regulatory processes.
AggRecetin, with its elevated concentration of Ristocetin A, transcends its role as a mere reagent, emerging as a key to unraveling the mysteries of platelet function. It opens a gateway to comprehend the intricate web of interactions defining hemostatic balance and offers valuable insights for advancing our knowledge in vital physiological processes.
Kindly explore the materials provided on this page, including the AggRecetin Reagent Product Data Sheet and Routine Agonist Expected Results Chart. Additionally, refer to the and the AggRecetin Instruction for Use (IFU) and the AggRecetin Safety Data Sheet (SDS), available in six languages. For our European and United Kingdom customers and distributors, carefully review the AggRecetin EU Declaration of Conformity and the AggRecetin UK Declaration of Conformity to ensure compliance and tailored understanding for these specific regions. This information is crucial for gaining a comprehensive understanding of the product details and specifications.
YOU MAY ALSO BE INTERESTED IN:
